Figure. Noncontrast axial CT (A) shows the isodense mass (arrow) arising from the posterolateral wall of the left maxillary sinus. On MRI, axial noncontrast Tl-weighted (B) and T2-weighted (C) imaging and coronal T2-weighted imaging (D) demonstrate the inhomogeneous mass (arrows). No enhancement was seenfollOWing contrast administration (not shown) .
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A 72-year-old man presented with a 3-month history of a painful, nonhealing sore on his left upper gingiva. Computed tomography (CT) without contrast demonstrated a well-defined 2.1 x I.s-cm expansile mass arising from the posterolateral wall of the left maxillary sinus. anterolateral to the base of the pterygoid plate (figure. A). Subsequent magnetic resonance imaging (MRI) showed that the mass was heterogeneously enhancing (figure. B, C, and D).
The patient underwent excisional biopsy of the mass. Microscopically. the specimen consisted of a chondroid-producing neoplasm. The lesion was made up of atypical chondrocytes along with multinucleated forms. In some areas. the cellularity was markedly increased, and increased mitotic activity and atypical mitoses were also documented. In other areas. the lesion exhibited no chondroid characteristics. Overall. the features of the biopsy specimen were consistent with a high-grade (grade 3) chondrosarcoma.
Chondrosarcomas comprise a heterogeneous group of malignant bone tumors that have the distinction of producing chondroid (cartilaginous matrix) but not osteoid. which differentiates them from osteosarcomas .I This neoplasm accounts for 10 to 20% of all primary bone malignancies. and it is the second most common bone sarcoma after osteosarcoma.' Chondrosarcomas of the head and neck are uncommon. accounting for no more than 12% of all cases of chondrosarcoma and 0.1% of all head and neck malignancies.' Within in the head and neck. this and comedonecrosis areas (figure 1). Cribriform and "Roman bridge" configurations are common ( figure  2) . The tumor cells exhibit remarkable pleomorphism, with pink, granular cytoplasm surrounding irregular nuclei with prominent nucleoli (figure 2). Oncocytic change is common. There are usually many mitoses, including atypical forms. Several variants are recognized, including spindled. sarcomatoid, mucin -rich, micropapillary, and osteoclast-type giant cells. The neoplastic cells are reactive with several keratins, including CK5/6, EMA, and CEA, while demonstrating a strong and diffuse membranous HER-2/ neu immunoreaction and strong nuclear positivity for androgen receptor (figure 3). In general, salivary duct carcinoma must be distinguished from metastatic breast carcinoma, poorly differentiated squamous cell carcinoma, cystadenocarcinoma, and oncocytic carcinoma. 
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malignancy usually resides in the anterior maxilla and sinonasal structures.' The median age at diagnosis is 52 years.' The neoplasm characteristically presents with painless swelling that sometimes becomes painful in later stages. Findings on CT include a hypodense soft-tissue mass with scattered chondroid matrix calcifications. These calcifications characteristically appear in a ringlike or arc-whorl pattern; amorphous or absent calcifications are suggestive of a high-grade tumor. MRI may further define the extent of soft-tissue involvement. Characteristic MRI findings are an increased T2 signal and heterogeneous enhancement on Tl-weighted imaging with contrast. 5 Reported 5-year survival rates range between 32 and 87.5%.2 The most effective treatment modality is wide surgical resection with clear margins, as residual disease is a primary factor in recurrence. Although adjuvant radiotherapy has not been shown to have a significant effect on survival, it is used in cases of incomplete resection, high-grade lesions, and disseminated disease.'
In our case, the patient was found to have a chondrosarcoma of the left maxilla with extension into the infratemporal fossa. Our case was presented to the multidisciplinary planning conference, and recommendations were made for maxillectomy and resection of the infratemporal fossa followed by radiotherapy.
